Boston Scientific Bags $104M IP Arbitration Deal
Boston Scientific Corp. has struck a deal with Israeli medical device company Medinol Ltd. to end their intellectual property war over drug-coated heart stents, with Medinol shelling out $104 million to...To view the full article, register now.
Already a subscriber? Click here to view full article